Clinical criteria of Parkinson's disease;Klinik des morbus Parkinson

Therapeutische Umschau

Volumn 64, Issue 1, 2007, Pages 5-8

  Ransmayr, Gerhard ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; BENSERAZIDE PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PARKIN;

AKINESIA; BALANCE DISORDER; BODY POSTURE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; GAIT; GENE MUTATION; HUMAN; HYPERSALIVATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; REVIEW; RIGIDITY; RIGOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREMOR;

AGE FACTORS; AGED; ANTIPARKINSON AGENTS; COGNITION DISORDERS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGONISTS; HUMANS; LEVODOPA; MIDDLE AGED; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33846806060     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.64.1.5     Document Type: Review

References (33)

1. Rascol O, Brooks DJ, Korczyn AD, et al. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med 2000; 342: 1484-91.
2. Lücking CB, Dürr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med 2000; 25: 1560-7.
3. Rawal N, Periquet M, Lohmann E, et al. New parkin mutations and atypical phenotypes in families with autosomal recessive parkinsonism. Neurology 2003; 68: 1378-81.
4. Shapira AHV. Etiology of Parkinson's disease. Neurology 2006; 66 (Suppl 4): S10-23.
5. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiat 1992; 55: 181-4.
6. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialised movement disorder service. Brain 2002; 125: 861-70.
7. Delwaide PJ, Gonce M. Pathophysiology of Parkinson's signs. In: Jankovic J and Tolosa E (eds): Parkinson's disease and movement disorders. Baltimore: Williams & Wilkins, 1998: 159-75.
8. Bonnet AM, Loria Y, Saint-Hilaire M-H, Lhermitte F, Agid Y. Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions. Neurology 1987; 37: 1539-42.
9. Blin J, Dubois B, Bonnet AM, Vidailhet M, Brandabur M, Agid Y. Does ageing aggravate Parkinsonian disability. J Neurol Neurosurg Psychiatry 1991; 54: 780-2.
10. Azher SN, Jankovic J. Camptocormia: pathogenesis, classification, and response to therapy. Neurology 2005; 65: 355-9.
11. Fahn S, Elton R. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D (eds): Recent developments in Parkison's disease. New York: Macmillan, 1987.
12. Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson's disease: Clinical and prognostic implications. Neurology 1985; 35: 522-6.
13. Cubo E, Gracies JM, Benabou R, Olanow CW, Raman R, Leurgans S, Goetz CG. Early morning off-medication dyskinesias, dystonia, and choreic subtypes. Arch Neurol 2001; 58: 1379-82.
14. Schrag A, Quinn N. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study. Brain 2000; 123: 2297-305.
15. Sage JI, Mark MH. Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to levodopa profile. Ann Neurol 1995; 37: 120-2.
16. Streifler M, Avrami E, Rabey JM. L-Dopa and the secretion of sebum in Parkinsonian patients. Eur Neurol 1980; 19: 43-8.
17. Edwards L, Quigley EMM, Hofman R. Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study. Mov Disord 1993; 8: 83-6.
18. Goetz CG, Lutge W, Tanner CM. Autonomic dysfunction in Parkinson's disease. Neurology 1986; 36: 73-5.
19. Wenning GK, Scherfler C, Granata C, et al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with post-mortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry 1999; 67: 620-3.
20. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996; 46: 1470.
21. Andersen JB, Hebjørn S, Frimont-Møller C, et al. Disturbances of micturition in Parkinson's disease. Acta Neurol Scand 1976; 53: 161-70.
22. Nausieda PA, Weiner WJ, Kaplan LR, Weber S, Klawans HL. Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis: Clin Neuropharmacol 1982; 5: 183-94.
23. Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Pain in Parkinson's disease. Mov Disord 1986; 1: 45-9.
24. Shulman LM, Singer C, Bean JA, Weiner WJ. Internal tremor in patients with Parkinson's disease. Mov Disord. 1996; 11: 3-7.
25. Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfactation in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's disease. Arch Neurol 1998; 55: 84-90.
26. Friedman JH, Friedman MA. Fatigue in Parkinson's disease: A nine-year follow-up. Mov Disord 2001; 16: 1120-2.
27. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson's disease. Arch Neurol 2003; 60: 387-92.
28. Lees AJ and Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983; 106: 257-70.
29. Emre M. Dementia associated with Parkinson's disease. Lancet Neurology 2003; 2: 229-37.
30. Poewe W, Luginger E. Depression in Parkinson's disease: Impediments to recognition and treatment options. Neurology 1999; 52 (Suppl 3): S2-S6.
31. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000; 68: 423-8.
32. Pezzella FR, Colosimo C, Vanacore N, et al. Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease. Mov Disord 2005; 20: 77-81.
33. Hughes AJ, Lees AJ, Stern GM. Challenge tests to predict the dopaminergic response in untreated Parkinson's disease. Neurology 1991; 41: 1723-5.